fda ruling on compounded semaglutide The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the FDA warns against using compounded
Description
Support each other through the process rather than turning it into a competition

Semaglutide is the active ingredient found in widely used medication prescribed for type 2 diabetes (Ozempic) and obesity (Wegovy)

Hormones (Athens) 21(1):4149 Polyzos SA, Kang ES, Boutari C, Rhee E-J, Mantzoros CS (2020) Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
If you experience severe abdominal pain, jaundice, or difficulty passing gas while on these medications, seek immediate medical attention, as these symptoms could indicate serious issues like pancreatitis or gallbladder complications
Your body preferentially burns stored fat rather than muscle for energy

References Hunter DJ, Bierma-Zeinstra S